Ledger.Open graph →
SEC Form D · filed February 24, 2015

NGM BIOPHARMACEUTICALS INC

Offering
$60.0M
Sold
$20.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SOUTH SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Peter V. Svennilson · South San Francisco, CADirectorMchenry T. Tichenor, Jr · Dallas, TXDirectorDavid V. Goeddel · South San Francisco, CADirectorMark V. Leschly · Palo Alto, CADirectorDavid V. Schnell · Palo Alto, CADirectorJin-Long Chen · South San Francisco, CAExec · DirectorWilliam J. Rieflin · South San Francisco, CAExec · DirectorGail Naughton · Encinitas, CADirectorJames R. Wymer · Fairview Park, OHDirectorPeter Rathjens · Grand Cayman, Cayman IslandsDirectorMichael Hormaechea · Boise, IDDirectorJames J. Lynch · HARTFORD, CTExec · DirectorSteven J. Kapiloff · HARTFORD, CTExec · DirectorMonika Wingate · Madison, WIDirectorJane Boutelle · Madison, WIExec · DirectorMichael Phippen · Mill Valley, CAExec · DirectorElliott Elbaz · Mill Valley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗